SCIENTIFIC BACKGROUND

ACTC1, ADAMTS10, ARHGAP31, BMPR2, CHD7, CITED2, CREBBP, DOCK6, DTNA, EHMT1, ELN, EOGT, EP300, EVC, EVC2, FBN1, FBN2, FLNA, FLT4, FOXC1, FOXH1, FOXP1, GATA4, GATA5, GATA6, GJA1, GPC3, JAG1, KDM6A, KMT2D, MED12, MED13L, MGP, MYH11, MYH6, NIPBL, NKX2-5, NKX2-6, NOTCH1, NOTCH2, NR2F2, NSD1, PITX2, RBM10, RBPJ, SALL1, SALL4, SEMA3E, SMAD4, SMAD6, TAB2, TBX1, TBX20, TBX3, TBX5, TFAP2B, TGFBR1, TGFBR2, TLL1, ZEB2, ZFPM2

Scientific Background

The molecular basis of many CHD syndromes has been identified. Monogenic syndromes can include, among others, Holt-Oram, Char, Ellis-van Creveld, Adams-Oliver and Kabuki syndrome. Holt-Oram syndrome is an autosomal dominant disorder most commonly involving the atrial or ventricular septum (ASD or VSD). 70% of cases are caused by a heterozygous pathogenic variant in TBX5. Char syndrome is autosomal dominantly inherited with patent ductus arteriosus (PDA) as the primary cardiac finding, but also other heart defects such as VSD have been reported. ~50% of families with a clinical diagnosis for Char syndrome have a heterozygous pathogenic variant in TFAP2B. Ellis-van Creveld syndrome (EVC) is an autosomal recessive skeletal dysplasia associated with a primary atrial septation defect resulting in a common atrium. Two-thirds of cases of EVC are caused by homozygous or compound heterozygous variants in EVC or EVC2. Adams-Oliver syndrome (AOS) can be inherited autosomal dominantly or recessively. Malformations can include heart, scalp and limbs. Pathogenic variants in ARHGAP31, DOCK6, RBPJ, EOGT, NOTCH1, and DLL4 have been reported. Kabuki syndrome (KS) has both X-linked and autosomal dominant pathogeneses. CHDs occur in 40% to 70% of individuals with KS. The most common cardiac malformations are coarctation of the aorta, ASD, and VSD. KS is mainly caused by pathogenic variants in the KMT2D and KDM6A genes.

 

References

Pierpont et al. 2018, Circulation. Nov 20;138

GENES

ACTC1, ADAMTS10, ARHGAP31, BMPR2, CHD7, CITED2, CREBBP, DOCK6, DTNA, EHMT1, ELN, EOGT, EP300, EVC, EVC2, FBN1, FBN2, FLNA, FLT4, FOXC1, FOXH1, FOXP1, GATA4, GATA5, GATA6, GJA1, GPC3, JAG1, KDM6A, KMT2D, MED12, MED13L, MGP, MYH11, MYH6, NIPBL, NKX2-5, NKX2-6, NOTCH1, NOTCH2, NR2F2, NSD1, PITX2, RBM10, RBPJ, SALL1, SALL4, SEMA3E, SMAD4, SMAD6, TAB2, TBX1, TBX20, TBX3, TBX5, TFAP2B, TGFBR1, TGFBR2, TLL1, ZEB2, ZFPM2
How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more